Home Journal Excerpts Breast Implants
Breast Implants
breastimplantIn comparison with the general population, this study, like previous investigations, found excess risks of cervical, vulvar, and lung cancers among women with previous augmentation mammoplasties. Although the internal analyses suggested similar risks for most cancer sites between implant and comparison patients, a few differences persisted, including higher risks for respiratory and brain cancers, and leukemia


Controversy has surrounded breast implants for quite a number of years. Although the CDC website (http://www.fda.gov/cdrh/breastimplants/birisk.html) doesn't mention a risk of other cancers, this newer study shows that there is a concern in regards to later developing lung or brain cancer or possibly leukemia. What's of interest is that the longer the follow-up the greater the risk of respiratory cancer developing - an almost 3 times increased rate of risk at 15 years. This study should throw up a huge red flag for people considering this type of procedure.

Cancer Risk at Sites Other than the Breast Following Augmentation Mammoplasty PDF Print E-mail
Tuesday, 01 May 2001 00:00
“Silicone breast implants were first introduced in the United States in the early 1960s and became widely sold during the next three decades. Although it has been estimated that between 800,000 and one million women received the devices, there has been limited assessment of their long-term effects. Most attention has focused on connective tissue disorders, but the range of immunologic disturbances observed in women with implants suggests other chronic diseases, including cancer. The greatest attention regarding cancer risk has focused on breast cancer, given clinical reports of an association and observation that mammographic visualization is compromised by implants. Some, although not all, epidemiological studies have suggested that breast cancer risk might be reduced among women with implants, although the biologic mechanism remains undefined.”

“Other cancers have not been well evaluated, despite some animal as well as clinical data to suggest potential risks for selected sites, including sarcomas and certain hematopoietic malignancies. There have only been limited attempts to address the relationships epidemiologically, and the available studies suffer from small numbers of events and absence of information on most potential confounding variables.”
Last Updated on Thursday, 25 June 2009 02:23